<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Clinical research / Pharmacology / Pharmaceutical industry / Therapeutics / Medical device / Validation / FDA / Center for Devices and Radiological Health / Food and Drug Administration / Medicine / Health
Date: 2010-12-01 20:19:45
Pharmaceutical sciences
Clinical research
Pharmacology
Pharmaceutical industry
Therapeutics
Medical device
Validation
FDA
Center for Devices and Radiological Health
Food and Drug Administration
Medicine
Health

[removed]Federal Register / Vol. 68, No[removed]Wednesday, July 23, [removed]Notices TABLE 1.—ESTIMATED ANNUAL REPORTING BURDEN1 21 CFR Section

Add to Reading List

Source URL: www.gpo.gov

Download Document from Source Website

File Size: 159,76 KB

Share Document on Facebook

Similar Documents

JUUL 904(b) Collection Letter

JUUL 904(b) Collection Letter

DocID: 1xW1m - View Document

October 12, 2018 VIA UPS and Electronic Mail Mr. J. Christopher Prue, R.Ph. MBA Vice President, Product Regulatory Science Fontem U.S. IncSouth Tyron Street, Suite 350

October 12, 2018 VIA UPS and Electronic Mail Mr. J. Christopher Prue, R.Ph. MBA Vice President, Product Regulatory Science Fontem U.S. IncSouth Tyron Street, Suite 350

DocID: 1xVUf - View Document

October 12, 2018 VIA UPS and Electronic Mail Mr. Thomas Vo Chief Executive Officer Baton LLCNortheast 91st Street

October 12, 2018 VIA UPS and Electronic Mail Mr. Thomas Vo Chief Executive Officer Baton LLCNortheast 91st Street

DocID: 1xVSE - View Document

Netzneutralität: Verhaltensrichtlinien Die unterzeichnenden Netzbetreiber stehen für ein offenes Internet ein. Was meinen die Fernmeldedienstanbieter (FDA) damit? Dieser Verhaltenskodex enthält Richtlinien, welche ein

Netzneutralität: Verhaltensrichtlinien Die unterzeichnenden Netzbetreiber stehen für ein offenes Internet ein. Was meinen die Fernmeldedienstanbieter (FDA) damit? Dieser Verhaltenskodex enthält Richtlinien, welche ein

DocID: 1xVLj - View Document

September 12, 2018 Reynolds American Inc. 401 N. Main Street Winston Salem, N.CDear Mr. Mike Ogden: Your company is currently marketing Vuse, an electronic nicotine delivery system (ENDS) product, which

September 12, 2018 Reynolds American Inc. 401 N. Main Street Winston Salem, N.CDear Mr. Mike Ogden: Your company is currently marketing Vuse, an electronic nicotine delivery system (ENDS) product, which

DocID: 1xVJp - View Document